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Background: Intracranial aneurysms located at the bifurcation of the middle cerebral 
artery (MCA) can often be challenging for the neurointerventionalist. We aimed to evaluate 
the efficacy and safety of flow diverting stents (FDS) in the treatment of these aneurysms.
Materials and methods: We retrospectively reviewed our prospectively maintained 
database to collect information for all patients with unruptured saccular bifurcation MCA 
aneurysms treated with FDS between January 2010 and January 2016. In addition 
to demographic data, we recorded the location, aneurysm characteristics, previous 
treatments, number and type of FDS, complications, and clinical and angiographic 
follow-up.
results: Our search identified 13 patients (7 males) with an average age of 61.7 years 
(47–74 years). All patients had a single bifurcation aneurysm of the MCA, and none of the 
aneurysms were acutely ruptured. The average fundus size of the saccular aneurysms 
was 3 mm (range 1.5–10 mm). Follow-up studies were available for 12 patients. Based 
on the most recent follow-up angiograms, six aneurysms (50%) were totally occluded; 
five aneurysms (41.7%) showed only a small remnant; and one aneurysm (8.3%) 
remained unchanged. One patient suffered from an ischemic stroke with resultant per-
manent hemiparesis (mRS 3). In another case, there was an in-stent thrombosis during 
the intervention, which resolved upon intra-arterial infusion of Eptifibatide (mRS 0). There 
were no intra-operative vessel or aneurysm ruptures and no mortalities. Angiography of 
the covered MCA branches showed no change in the caliber or flow of the vessel in six 
(50%), a reduction in caliber in five (41.7%), and a complete occlusion in one (8.3%). All 
caliber changes and occlusions of the vessels were asymptomatic.
conclusion: In our series, 91.7% of treated MCA bifurcation aneurysms were either 
completely occluded or showed only a small remnant with a good safety profile. Flow 
diversion of MCA bifurcation aneurysms should be considered as an alternative treat-
ment strategy when microsurgical clipping or alternative endovascular treatment options 
are not feasible.
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inTrODUcTiOn
Since the publication of the International Subarachnoid 
Aneurysm Trial, intracranial aneurysms are being increasingly 
treated via the endovascular approach as an alternative for 
craniotomy and surgical clipping (1). Aneurysms of the middle 
cerebral artery (MCA) remain, however, challenging for the neu-
rointerventionist as they most commonly arise at a bifurcation of 
the vessel and frequently have a wide neck that can incorporate 
one or more branches (2), rendering traditional coiling difficult 
and necessitating the use of adjunctive devices such as balloon 
remodeling (3–7) or stent-assisted coiling (8–12). Over the last 
few years, flow diversion has proved to be a feasible and efficacious 
approach for the treatment of sidewall and dissecting aneurysms 
(13–19) even though long-term clinical data are still unavailable. 
The role of flow diverter stents (FDS) in treating bifurcation 
aneurysms remains, however, unclear. In this report, we review 
our experience in treating MCA bifurcation aneurysms with 
flow diversion as the primary approach or secondary therapy 
after previous coiling or clipping with subsequent recanalization/
aneurysm residual.
PaTienTs anD MeThODs
Population
We retrospectively reviewed our prospectively maintained data-
base to identify patients with aneurysms of the MCA bifurcation 
who were treated with flow diversion. Records were made of 
demographic data, clinical presentation, location and morphology 
of the aneurysms, the endovascular procedure, the postoperative 
complications, and the latest angiographic and clinical follow-up.
Definition of Mca Bifurcation aneurysm
We chose to categorize aneurysms arising at the first main 
division of the M1 trunk and those arising at an early division 
of a dominant superior or inferior trunk as MCA bifurcation 
aneurysms. Aneurysms of the M1 segment and distal to the MCA 
bifurcation were excluded.
endovascular Treatment
Informed consent was obtained prior to the intervention in all 
patients. A loading dose of two antiplatelet agents (aspirin 100 mg 
per day and clopidogrel 75 mg per day) was administered in every 
case, and the adequacy of the antiplatelet therapy was measured 
using the Multiplate Analyzer (Roche, Germany). Patients found 
resistant to clopidogrel received 2 × 90 mg ticagrelor daily. All 
therapeutic interventions were performed under general anes-
thesia. Arterial access was carried out through a standard 6Fr 
right common femoral route in all cases. A bolus dose of heparin 
(5,000 IU) was administered after securing the introducer sheath 
followed by repeat bolus doses every hour to maintain the 
activated clotting time between 2 and 2.5 times the baseline. The 
post-procedural antiplatelet regimen consisted of clopidogrel/
ticagrelor continued for 12  months following treatment and 
aspirin continued for life.
A pipeline embolization device (PED) was used in one case 
(Covidien, Irvine, CA, USA), the p64 flow modulation device 
(Phenox, Bochum, Germany) was used in all other cases. The 
choice of flow diverter was down to the operator, and we only 
have the p64 and PED available in our department. The PED 
is one of the most widely studied devices and is made of 25% 
platinum and 75% nickel–cobalt–chromium alloy with a poros-
ity of 65–70%. It is available in a variety of different sizes and 
diameters and multiple telescoped PED’s can be used to alter the 
porosity (20). The p64 is a braided flow diverting stent composed 
of 64 nitinol wires. Two platinum wires are wrapped around the 
shaft and assist in the radio opacity of the device. The 64 wires are 
grouped into 8 bundles proximally, with each bundle consisting 
of 8 wires. A radio-opaque marker is attached to end of each of 
these bundles. The porosity of the device is 51–60%. The p64 is 
unique amongst flow diverters in that it is mechanically detached 
and can be resheathed even after complete deployment.
clinical and angiographic Follow-up
All patients were evaluated clinically and neurologically prior to 
the treatment and during the postoperative hospital stay, another 
clinical and neurological evaluation was performed at every 
follow-up as well. Initial follow-up catheter angiography was 
performed at 3 months. The extent of the aneurysmal occlusion 
was graded as:
•	 1—total occlusion, no contrast filling of the aneurysm sac 
(Raymond Roy I)
•	 2—subtotal occlusion, minor residual sac filling or neck rem-
nant (Raymond Roy II)
•	 3—incomplete occlusion, substantial residual sac filling 
(Raymond Roy III)
•	 4—unchanged, patent aneurysmal sac with constant morphol-
ogy compared to the pretreatment angiogram.
resUlTs
Population
There were 13 patients matching our inclusion criteria (7 males) 
with an average age of 60 years (42–76 years). The treated aneu-
rysms were equally distributed between right and left. Three 
patients had a second aneurysm at a different location, one 
patient had two and another patient had four other intracranial 
aneurysms located elsewhere. All aneurysms were saccular with 
a fundus size ranging from 1.5 to 10 mm (average fundus size 
3 mm) and with the exception of one case all aneurysms had a 
dome/neck ratio of less than 1.5. Twelve aneurysms were located 
at the fist main MCA bifurcation (early bifurcation in two cases), 
one aneurysm was located at the bifurcation of each of the 
superior and inferior trunk. All patients were treated on an elec-
tive basis. The two fusiform aneurysms were previously clipped 
with incomplete occlusion. Four of the saccular aneurysms were 
previously treated by other modality (three were coiled and in one 
case there was an enlarging neck remnant after clipping and then 
coiling). The results are summarized in Table 1.
Feasibility
The delivery of the FDS was unproblematic in all cases. A single 
flow diverter was used in all cases. A PED was used in one 
TaBle 1 | Demographics, aneurysm characteristics, clinical, and radiological follow-up.
Patient 
no.
gender age side Dome 
(mm)
neck 
(mm)
Previous 
treatments
FDs (no. × type) Occlusion covered branch complications change in 
baseline 
mrs
1 m 60 L 2 2 Surgery, coils 1 × p64 2, RRC II Unchanged N N
2 m 64 R 2 2 N 1 × p64 1, RRC I Asymptomatic occlusion N N
3 f 47 L 1.5 1.5 Coils 1 × p64 1, RRC I Unchanged N N
4 f 50 L 2 2 Coils 1 × p64 1, RRC I Reduction in caliber N N
5 f 60 R 4 4 N 1 × p64 2, RRC II Reduction in caliber N N
6 m 58 R 2 3 N 1 × p64 2, RRC II Reduction in caliber N N
7 m 60 L 3 4 N 1 × p64 1, RRC I Unchanged N N
8 m 76 R 10 3.5 N 1 × p64 2, RRC II Reduction in caliber N N
9 f 74 R 4 1.5 N 1 × p64 4 Reduction in caliber N N
10 m 58 L 2 2 N 1 × p64 NA NA N N
11 m 71 L 2 3 N 1 × p64 2, RRC II Unchanged Stroke Y (mRS 3)
12 f 59 L 3 1 N 1 × p64 1, RRC I Unchanged Asymptomatic 
thrombosis
N
13 f 65 R 2 2 N 1 × pipeline 
embolization device
1, RRC I Unchanged N N
3
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case; all other patients were treated using the p64 flow modula-
tion device.
angiographic Follow-up
Follow-up studies were available for 12 patients with first 
follow-up catheter angiography performed at mean 3.1 months 
after treatment. Delayed angiography was performed at mean 
15.8 months. There was complete aneurysmal occlusion in six 
cases (50%) (Figure  1). Near-complete occlusion with only a 
neck remnant was achieved in a further five cases (41.7%). 
A single case remained unchanged in our series; therefore, 
complete or near-complete occlusion was achieved in 91.7% 
of our cases.
The covered branches remained unchanged in caliber and 
flow in six cases (50%). In five cases, there was a reduction in the 
caliber of the covered branch but the vessel remained patent with 
anterograde flow (Figure 1). There was a single case of asympto-
matic occlusion of the covered branch (8.3%). All the cases where 
the covered vessel caliber was reduced or completely occluded 
were clinically asymptomatic.
complications
There was one case of an immediate thrombosis of the FDS, which 
resolved secondary to intra-arterial infusion of Eptifibatide and 
the patient recovered without neurological sequelae. One patient 
developed hemiparesis four days after the implantation of the 
FDS. The emergent MRI showed restricted diffusion in the basal 
ganglia and centrum semiovale. The immediate angiogram 
showed no in-stent thrombosis or vessel occlusion. Although the 
exact cause of the infarction in this case is not know, it is possible 
that a drop in blood pressure plus reduced flow through the FDS 
may have resulted in decreased perfusion to the infarcted region 
(Figure 2).
DiscUssiOn
The MCA is the larger of the two terminal branches of the 
internal carotid artery. Over its course the MCA is divided into 
four segments: the M1 (sphenoidal) segment, the M2 (insular) 
segment, the M3 (opercular) segment, and the M4 (cortical) 
segments (21). The branching pattern of the main trunk of the 
MCA is variable with a bifurcation being the most common: 
absence of a main division in 6%, bifurcation in 64%, trifurcation 
in 29%, and quadrifurcation in 1% of people. The location of the 
bifurcation depends on the length of the M1 Segment. The main 
divisions are of equal diameter in only 15% of the cases with the 
inferior trunk being dominant in 50% (22).
Aneurysms of the MCA occur most often at the main divi-
sion point (23). In a review of a population-based series of 3,005 
patients with 4,253 intracranial aneurysms, 1,704 were MCA 
aneurysms, of which 1,385 (81%) were located at the main 
bifurcation of the MCA. The percentage of aneurysms located 
at the main bifurcation was even higher among ruptured MCA 
aneurysms (89%) (2). Elsharkawy et al. (24) analyzed 1,009 aneu-
rysms located on the MCA to determine if there were particular 
risk factors associated with a risk of rupture. In this study, loca-
tion at the MCA bifurcation, wall irregularity, and non-spherical 
shape were all identified as risks for rupture. Interestingly, it was 
also seen that 26% of patients with ruptured MCA bifurcation 
aneurysms were classified as small (<7 mm) and that this was 
significantly greater than the percentage of patients with large 
(15–24 mm) and giant (≥25 mm) aneurysms, which presented 
with rupture in 15 and 2% of cases, respectively. This highlights, 
that at least in this location, small aneurysms carry a not insig-
nificant risk of rupture.
From an anatomical perspective MCA bifurcation aneurysms 
are often wide necked and may incorporate one or more branches. 
This can be challenging for traditional endovascular approaches 
such as coiling without adjunctive devices (2, 25, 26). In the study 
of Jin et  al. (27), 103 aneurysms of the MCA bifurcation were 
treated with only coiling. The post-coiling angiogram in these 
patients showed a complete occlusion in 27.2% and residual 
neck in 58.3%. At follow-up angiography (mean 30  months), 
recanalization was seen in 25% of cases and just over 20% of 
these recanalized aneurysms were deemed completely occluded 
on post-coiling angiography. Other authors have also published 
FigUre 2 | a patient treated with a single p64 FDs for a middle cerebral artery bifurcation anerurysm. An incidental untreated bifurcation aneurysm (a). 
The same aneurysm in a different projection shows a wide necked saccular MCA bifurcation (B). There were no intra-operative complications and immediately 
post-procedure the patient awoke with baseline neurology. Five days post-procedure, the patient developed a right hemiparesis. Catheter angiography at this time 
(c) showed all branches were patent with anterograde flow and minimal filling of the aneurysm. An MRI showed restricted diffusion (D).
FigUre 1 | a small neck recurrence after a previous coiling (a). Repeat treatment using coils would have necessitated a stent into the inferior branch, and 
therefore, it was felt an alternative strategy would be to place a single p64 FDS into the superior middle cerebral artery trunk. A follow-up angiogram performed 
3 months later (B) showed on contrast enhancement of the aneurysm and a reduction in the caliber of the size of the inferior trunk but with persistent anterograde 
flow. The patient was neurologically intact, and there were no clinical consequences of the vessel modification.
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their experience of MCA aneurysm treatment involving endo-
vascular techniques; for example, Bracard et  al. reviewed 152 
MCA aneurysms treated by coil occlusion. They showed 
complete or near-complete occlusion in 84.2% of aneurysms, 
of which 80.2% persisted at the 5-year follow-up (28). In a large 
retrospective analysis of 300 consecutive endovascularly treated 
MCA aneurysms (80% ruptured), complete or near-total occlu-
sion was achieved in 91% of cases (25). Similarly, Zaidat et  al. 
(29) reviewed their endovascular treatment of 161 consecutive 
MCA aneurysms and reported technical feasibility of 98.8% and 
a retreatment rate of 11%. In the meta-analysis of 12 studies 
performed by Brinjikji et al., they noted an overall occlusion rate 
(complete or near-complete occlusion) of 82.4% with an overall 
procedure-related permanent morbidity/mortality rate of 5.1% 
for unruptured aneurysms. While these latter studies are useful, 
a major difficulty in their interpretation is they include all MCA 
aneurysms together with no separation based on anatomical 
location.
In order to address the various anatomical abnormalities 
that may be encountered when treating MCA bifurcation aneu-
rysms, various techniques have been developed and include: 
balloon remodeling (3–7), stent-assisted coiling (7–9, 11, 12), 
neck-bridging devices (30, 31), and intra-aneurysmal flow 
disrupters (32–35).
Eboli et al. (36) recently published their series of 184 MCA 
bifurcation aneurysms treated endovascularly. In this series, 
stent-assisted coiling was required in 70 cases (38%), and only 
3 cases (1.6%) required “Y” stenting. They achieved an initial 
total occlusion rate of 59.8%; however, on follow-up angiography 
(mean 41  months) complete aneurysm occlusion was seen in 
90.1% of patients with a further 6.1% of patients having a stable 
remnant. The overall peri-procedural morbidity was 3.8% and the 
mortality rate in the unruptured cohort was 0%.
The Woven EndoBridge [WEB (Sequent Medical, Aliso 
Viejo, CA, USA)] is an intra-saccular device designed to disrupt 
the intra-aneurysmal flow at the level of the neck to encourage 
intra-aneurysmal thrombosis. Although some authors reported 
high feasibility of this device with promising early and midterm 
post-procedural angiographic results (32–34), the follow-up 
study by Cognard and Januel reported worsening at follow-up 
in 71.5% in their series of 14 patients with wide-neck bifurca-
tion aneurysms (of which 11 were at the MCA bifurcation) 
with compression of the cage demonstrated in 8 of the 14 cases 
(37). Additionally, the available sizes of the WEB device may 
render it unsuitable to small wide-necked aneurysms. The 
pCONus (Phenox, Bochum, Germany) device is an electrolyti-
cally detachable self-expanding nitinol implant with four distal 
petals designed to open inside the aneurysm providing support 
for coiling of wide-neck bifurcation aneurysms. Aguilar-Pérez 
et  al. recently published their experience with the pCONus 
neck-bridging device for the treatment of wide-necked aneu-
rysms. This series included 11 MCA aneurysms with complete 
occlusion of 6 aneurysms (54.5%) at follow-up and only neck 
remnant in 3 cases (27.2%) (30).
Since their introduction, flow diverter stents (FDS) have 
gained popularity for the treatment of intracranial aneurysms. 
The occlusion of an aneurysm by FDS is initially by the promotion 
of intra-aneurysmal thrombosis through induced flow stasis. The 
blood’s flow though the struts of a FDS depends on flow demands 
and thus preserving the patency of covered branches where 
flow is needed (38). For example, even relatively small arteries 
such as the anterior choroidal artery remain patent after cover-
age by FDS as was recently shown by Neki et al. (39). Covered 
branches with an adequate collateral arterial supply, such as 
the ophthalmic artery, where the orbit enjoys a rich collateral 
blood supply through branches of the external carotid artery, 
frequently undergo spontaneous, asymptomatic occlusion (40). 
Rangel-Castilla et al. recently published their longer-term results 
of 82 aneurysms treated with FDS with an emphasis on covered 
branches (41). In this study of 76 covered ophthalmic arteries, 
10.5% were occluded (clinically asymptomatic), 28 posterior 
communicating arteries were covered with 10.7% of the vessels 
occluded (clinically asymptomatic), and 21 covered anterior 
choroidal arteries with no evidence of occlusion. This study also 
reported two cases where the anterior cerebral artery was covered 
and there was occlusion with filling of the A2 segment via the 
contralateral anterior cerebral artery. Therefore, there is evidence 
that branch occlusion can be asymptomatic. However, this may 
not necessarily be the case in more distal locations such as at the 
MCA bifurcation.
Yavuz et al. (42) used the PED to treat 25 MCA aneurysms 
located at or distal to the bifurcation in 21 patients and reported 
a complete occlusion in 21 of the cases (84%). There were no 
mortalities, and apart from one patient who developed ischemia 
several days after the procedure (which was attributed to vasos-
pasm by the authors), there were no significant peri-procedural 
morbidities. There was reduced filling of six and total occlu-
sion of three of the covered branches, all of which remained 
clinically asymptomatic. The authors concluded that the PED 
is a safe and feasible option in treating aneurysms arising at the 
MCA bifurcation. The results reported by Caroff et al. (43) were 
not so promising. In their retrospective review of 14 patients 
harboring 15 saccular MCA bifurcation aneurysms treated with 
FDS, the authors reported ischemic complications in 43% of the 
cases detected on MRI, and although, there were no mortalities, 
procedure-related morbidities reached 21% on follow-up, most 
of these were related to occlusion or slow flow in the covered 
branches. Complete occlusion was, however, achieved in only 
62% of the treated aneurysms. In another report by Briganti 
et al. (44), total occlusion of the MCA bifurcation aneurysms 
was achieved in 80% with the rest of the aneurysms being par-
tially occluded. This series included 14 patients harboring 15 
MCA aneurysms of which 13 were located at the MCA bifurca-
tion, all of which were treated using the PED. Of the 13 side 
branches covered by the PED, follow-up angiographic studies 
showed reduced flow in 6 and total occlusion of 3 of them. The 
authors reported ischemic complications in 27% of the cases 
with permanent neurological deficient in 21%. Topcuoglu et al. 
(45) recently published their series of 29 aneurysms of the MCA 
treated with flow diversion, 6 of which occurred at the true 
bifurcation of the MCA (defined as the division of the MCA in 
superior and inferior trunks). Of these 6 cases, all of which were 
treated with the Silk FDS (Balt, Montmercy, France), occlusion 
of the covered branch occurred in 50% of cases, none of which 
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resulted in morbidity or mortality. In our series, we achieved 
a complete occlusion in 50% of patients and near-complete 
occlusion in 41.7%. We had no mortalities and only one case of 
permanent morbidity. We believe, as with flow diversion used 
in other sites, that the aneurysms with near-complete occlusion 
will continue to occlude over time as neo-endothelialization 
occurs; however, longer-term follow-up is required. In a single 
case, the aneurysm showed no change at delayed angiography 
(9  months), and we are unable to explain this phenomenon. 
The patient had no background medical conditions that could 
potentially interfere with neo-endothelialization nor did 
they demonstrate any abnormal response to the antiplatelet 
medication.
Saleme et  al. (46) sought to clarify the role of covered 
branches and collateral supply. They compared remodeling of 
the side braches covered after the deployment of flow diverters 
dividing the aneurysms in two groups based on whether the 
territory supplied by the side branch received a direct collateral 
supply or not. This study included the placement of FDS across 
the anterior cerebral artery, the anterior communicating artery, 
the terminal ICA, and the MCA (51.4% of cases). They showed 
that in the group with a direct collateral supply 78.5% of covered 
branches had undergone narrowing or occlusion at 6 months, 
although no new strokes were seen on MR imaging. Hence, the 
authors suggest that symptomatic remodeling of covered side 
braches depends on the extent and type of collateral supply, and 
this is similar to the findings reported earlier by Rangel-Castilla 
et  al. (39–41). One explanation of the lower occlusion rate 
observed with flow diversion for bifurcation aneurysms might 
be the persistent flow through the covered braches incorporated 
by the aneurysm. Fahed et  al. (47) compared flow diversion 
with and without occlusion of the jailed branch in 14 wide-neck 
aneurysms induced in 8 canines and found that occlusion of the 
jailed branch resulted in better occlusion rates of aneurysmal 
occlusion. Patent aneurysms were associated with leaks or holes 
in the neo-intima covering the aneurysm neck. The authors 
concluded that persistent flow to the jailed branch is a potential 
cause of treatment failure after flow diversion for bifurcation 
aneurysms. Furthermore, it is also worth remembering that the 
porosity of FDS is known to alter with curves and this appears to 
be most marked for FDS deployed across bifurcation aneurysms 
and on the outer edge curves of vessels (48, 49). This effect has 
been studied for both the PED and the Silk flow diverters with 
similar results and it is likely that the same effect will be seen 
with the p64.
Despite the plethora of currently available modality for the 
treatment of MCA aneurysms, considering the relatively straight 
forward access, the good outcome after clipping and the ability 
for simultaneous removal of a space occupying hematoma in 
cases of ruptured aneurysms, a surgical approach remains the 
principal treatment of MCA aneurysms in many centers (2, 50, 
51). In their series of 282 ruptured and 261 unruptured MCA 
aneurysms, Rodríguez-Hernández and colleagues reported com-
plete aneurysm obliteration in 98.3% and good clinical outcomes 
in 92% of patients with unruptured and 70.2% with ruptured 
aneurysms (52). In a review of the literature by Yang and Haung, 
the authors favored the microsurgical approach for the definitive 
management of MCA aneurysms. The reviewed surgical series 
reported occlusion rates between 90 and 89.3% with good clinical 
outcomes in 92–100% of unruptured and 70–80% of ruptured 
MCA aneurysms treated with clipping. The authors also sug-
gested that the significantly higher retreatment rated and lower 
occlusion rates of the endovascular approach would offset the 
favorable clinical outcome in the short term of the less invasive 
approach (53).
Our study has several limitations. The sample size is small 
and the treated aneurysms are heterogeneous. Another limiting 
factor is that flow diversion was not the primary treatment 
in six cases (42.8%), rather implemented as a secondary 
therapy for persistent aneurysmal perfusion after coiling or 
clipping. The results are also limited by the relatively short 
follow-up period (13  months on average), especially because 
the definitive results of this modality depend on the progressive 
reduction of flow inside the aneurysmal sac. Although one type 
of flow diverter stents, namely the p64, was used in all but one 
case in our series, we believe that the relatively inferior results 
in comparison to other endovascular or surgical modalities 
are related to the special anatomic consideration of the MCA 
bifurcation, rather than the technical specification of the flow 
modulation device.
cOnclUsiOn
Based on our small series, flow diversion for the treatment of 
bifurcation MCA aneurysms is feasible with good angiographic 
results and acceptable complication rates. However, compared 
to the results of other endovascular techniques and to surgery, 
total occlusion of bifurcation MCA aneurysms seems to be less 
frequent with flow diversion. Therefore, we believe that flow 
diversion should be reserved for cases where other treatment 
modalities are deemed unfeasible or carry excessive risk.
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